SUNNY is a company engaged in the research, development, production and marketing of veterinary API’s, formulations and feed additives. We are privileged to have elite graduates from the most prestigious universities from our home country of China and abroad. SUNNY is also the final destination of many highly experienced and respected professionals from within the bio-pharmaceutical industry.

Established in partnership with Zhejiang University, one of the premiere education and research institutions in China, SUNNY has maintained a close working relationship with the university to ensure a leading position in research, technology, and production Exceptional quality has been the hallmark of Sunny’s corporate strategy for the past twenty years and it will continue to drive our success for the next twenty.

This focus on quality can best be demonstrated by our current leadership position amongst Chinese producers of Tiamulin and in the many certifications we have received:2007, Received Japanese 'Accreditation certification of Foreign Animal Drug Manufacturer'2010, Tiamulin obtained the EU- GMP-certificate2011, Australian GMP-approval for Tiamulin & Bambermycin by APVMA2012, Obtained COS/CEP Certificated 2010-313 for Tiamulin2013, EU-GMP-certificate for Tiamulin & Premixes, and for Colistin Sulfate2014, US FDA approval for Tiamulin2014, Became the only Chinese manufacturer of Nosiheptide & Enramycin GMP approved by Australian APVMA2016, Renew US FDA certificate for Tiamulin.

And with expansion of our current facility at Xinjiang and a new facility in Nantong, Sunny is positioned to become a global leader in the production of both animal and human pharmaceutical products

Mission：To deliver safe and high quality bio-pharmaceutical products, contributing to a healthier and better world.Vision：To be a leading manufacturer in the bio-pharmaceutical industry